v3.24.0.1
Fair Value Measurements - Additional Information (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Oct. 31, 2021
Jul. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Equity method investment $ 11,765 $ 32,455    
Research milestone payments 25,000      
Cash [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Research milestone payments 900      
AvenCell Member        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Equity method investment 11,800 32,500    
Investment Owned, Fair Value       $ 62,900
Sparing Vision SAS [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investment Owned, Fair Value 14,800 14,800 $ 14,800  
Kyverna [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investment Owned, Fair Value $ 10,000 $ 10,000